Evidence map›Paper›PMID 34912007›Full record

ArticleActa pharmacologica Sinica2022

Silibinin relieves UVB-induced apoptosis of human skin cells by inhibiting the YAP-p73 pathway.

Wei-Wei Liu, Fang Wang, Can Li, Xiao-Yu Song, Wuxiyar Otkur, Yu-Ying Zhu, Toshihiko Hayashi, Kazunori Mizuno, Shunji Hattori, Hitomi Fujisaki and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. On the mechanisms of epidermal stemness and differentiation.NPJ systems biology and applications · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. International journal of molecular sciences · 2023
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Wei-Wei LiuWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Fang WangWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Can LiWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Xiao-Yu SongWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Wuxiyar OtkurWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Yu-Ying ZhuWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Toshihiko HayashiWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Kazunori MizunoNippi Research Institute of Biomatrix, Toride, Ibaraki, 302-0017, Japan.
Shunji HattoriNippi Research Institute of Biomatrix, Toride, Ibaraki, 302-0017, Japan.
Hitomi FujisakiNippi Research Institute of Biomatrix, Toride, Ibaraki, 302-0017, Japan.
Takashi IkejimaWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China. ikejimat@vip.sina.com.
Shenyang Pharmaceutical University · CNJapan Institute of Leather Research · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excessive exposure to UVB induces skin diseases. Silibinin, a flavonolignan used for treating liver diseases, is found to be effective against UVB-caused skin epidermal and dermal cell damage. In this study we investigated the molecular mechanisms underlying. Human nonmalignant immortalized keratinocyte HaCaT cells and neonatal human foreskin fibroblasts HFFs were exposed to UVB irradiation. We showed that pre-treatment with silibinin dose-dependently decreased UVB-induced apoptosis of HaCaT cells. Furthermore, we showed that silibinin treatment inhibited nuclear translocation of YAP after UVB irradiation. Molecular docking analysis and DARTS assay confirmed the direct interaction of silibinin with YAP. Silencing YAP by siRNA had no influence on the survival of HaCaT cells, whereas inhibiting classical YAP-TEAD signaling pathway by siRNA targeting TEAD1 or its pharmaceutical inhibitor verteporfin further augmented UVB-induced apoptosis, suggesting that YAP-TEAD pathway was prosurvival, which did not participate in the protective effect of silibinin. We then explored the pro-apoptotic YAP-p73 pathway. p73 was upregulated in UVB-irradiated cells, but reduced by silibinin cotreatment. The mRNA and protein levels of p73 target genes (PML, p21 and Bax) were all increased by UVB but decreased by silibinin co-treatment. Inhibiting p73 by using siRNA reduced UVB-induced apoptosis, suggesting that downregulation of p73 was responsible for the cytoprotective effect of silibinin. In HFFs, the upregulated YAP-p73 pathway by UVB irradiation was also suppressed by silibinin. Collectively, YAP-p73 pathway is a major cause of the death of UVB-exposed epidermal HaCaT cells and dermal HFFs. Silibinin directly inhibits YAP-p73 pathway, exerting the protective action on UVB-irradiated skin cells.

Indexed as

SilymarinApoptosisHumansInfant, NewbornMolecular Docking SimulationRNA, Small InterferingSilybinRNA, Small InterferingSilybinSilymarinapoptosisHaCaT cellsHFF primary fibroblastsp73silibininTEADUVBverteporfinYAP

Identifiers

PMID34912007
PMCPMC9343358
OpenAlexW4200230151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.